Caribou Biosciences, Inc.
CRBU · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $11.2M | $9.99M | +11.7% |
| Operating income | −$148M | −$167M | +11.0% |
| Net income | −$148M | −$149M | +0.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $1.60M | $2.20M | −27.3% |
| Operating income | −$27.6M | −$29.4M | +6.1% |
| Net income | −$26.6M | −$27.5M | +3.3% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Caribou's revenue in FY2025?
- $11.2M in FY2025 (Fiscal year ended Dec 31, 2025), +11.7% vs $9.99M a year earlier, per its 10-K filed Mar 2026.
- Was Caribou profitable in FY2025?
- No: net income was −$148M and operating income −$148M in FY2025.
- What was Caribou's revenue in Q3 2026?
- $1.60M (−27.3% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.